Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AVAIL Vapor is a manufacturer and former retailer of premium e-liquid products and electronic nicotine delivery systems (ENDS). Founded in 2013 and headquartered in Richmond, Virginia, the company became one of the largest vape retailers in the United States, known for its high-standard cleanroom manufacturing and rigorous quality control. To address evolving federal regulations, the company established Blackbriar Regulatory Services, a division focused on analytical testing, human factors studies, and the preparation of Premarket Tobacco Product Applications (PMTAs) for the FDA. In 2021, due to the complex regulatory landscape and the PACT Act, AVAIL Vapor closed its retail operations and reached an agreement to sell its brands and manufacturing assets to Charlie's Holdings, Inc. The company's legacy remains centered on its early adoption of pharmaceutical-grade standards within the vapor industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AVAIL Vapor.